Howard Kaufman, MD : Episode 6
Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.
Related Videos
Related Content
